Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Chemistry ; 30(48): e202401319, 2024 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-38802321

RESUMEN

Mannosylerythritol lipids (MELs) are a class of amphipathic molecules bearing a hydrophilic 4-O-ß-D-mannopyranosyl-D-erythritol skeleton. Here, we designed and synthesized four kinds of MEL analogues R-MEL-A ([2R,3S]-erythritol type), S-mannosylthreitol lipid (MTL)-A ([2S,3S]-threitol type), R-MTL-A ([2R,3R]-threitol type), and α-S-MEL-A ([2S,3R]-erythritol type) using our previously reported boron-mediated aglycon delivery (BMAD) method and a neighboring group assisted glycosylation method. The selective cytotoxicity of the target compounds against cancer cells was evaluated, with R-MTL-A showing the highest selective cytotoxicity against human skin squamous carcinoma HSC-5 cells. Our findings suggest that R-MTL-A induces necrosis-like cell death against HSC-5 cells by decreasing cell membrane fluidity. R-MTL-A also exhibits an efficient recovery effect on damaged skin cells, indicating that R-MTL-A has potential as a lead compound for new cosmeceuticals with both cancer cell-selective toxicity and recovery effects on damaged skin cells.


Asunto(s)
Antineoplásicos , Glucolípidos , Humanos , Glucolípidos/química , Glucolípidos/farmacología , Línea Celular Tumoral , Antineoplásicos/farmacología , Antineoplásicos/química , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/patología , Diseño de Fármacos , Piel/efectos de los fármacos , Piel/patología , Ensayos de Selección de Medicamentos Antitumorales , Supervivencia Celular/efectos de los fármacos , Fluidez de la Membrana/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda